GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Bioscience International Holdings Inc (OTCPK:CBIH) » Definitions » Return-on-Tangible-Equity

Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) Return-on-Tangible-Equity : 0.00% (As of Nov. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Cannabis Bioscience International Holdings Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Cannabis Bioscience International Holdings's annualized net income for the quarter that ended in Nov. 2023 was $-0.61 Mil. Cannabis Bioscience International Holdings's average shareholder tangible equity for the quarter that ended in Nov. 2023 was $-0.84 Mil. Therefore, Cannabis Bioscience International Holdings's annualized Return-on-Tangible-Equity for the quarter that ended in Nov. 2023 was N/A%.

The historical rank and industry rank for Cannabis Bioscience International Holdings's Return-on-Tangible-Equity or its related term are showing as below:

CBIH' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -38.96   Med: 18.97   Max: 100.15
Current: 18.97

During the past 5 years, Cannabis Bioscience International Holdings's highest Return-on-Tangible-Equity was 100.15%. The lowest was -38.96%. And the median was 18.97%.

CBIH's Return-on-Tangible-Equity is ranked better than
80.28% of 933 companies
in the Drug Manufacturers industry
Industry Median: 6.31 vs CBIH: 18.97

Cannabis Bioscience International Holdings Return-on-Tangible-Equity Historical Data

The historical data trend for Cannabis Bioscience International Holdings's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabis Bioscience International Holdings Return-on-Tangible-Equity Chart

Cannabis Bioscience International Holdings Annual Data
Trend Dec06 Dec07 May09 May10 May11
Return-on-Tangible-Equity
- - 100.15 -38.96 18.97

Cannabis Bioscience International Holdings Semi-Annual Data
Dec06 Jun07 Dec07 Jun08 May09 Nov09 May10 Nov10 May11 Nov11 Nov22 Nov23
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.15 5.30 14.89 -1.24 -

Competitive Comparison of Cannabis Bioscience International Holdings's Return-on-Tangible-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Bioscience International Holdings's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabis Bioscience International Holdings's Return-on-Tangible-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Bioscience International Holdings's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Cannabis Bioscience International Holdings's Return-on-Tangible-Equity falls into.



Cannabis Bioscience International Holdings Return-on-Tangible-Equity Calculation

Cannabis Bioscience International Holdings's annualized Return-on-Tangible-Equity for the fiscal year that ended in May. 2011 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: May. 2011 )  (A: May. 2010 )(A: May. 2011 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: May. 2011 )  (A: May. 2010 )(A: May. 2011 )
=10.457/( (48.083+62.165 )/ 2 )
=10.457/55.124
=18.97 %

Cannabis Bioscience International Holdings's annualized Return-on-Tangible-Equity for the quarter that ended in Nov. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Nov. 2023 )  (Q: Nov. 2022 )(Q: Nov. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Nov. 2023 )  (Q: Nov. 2022 )(Q: Nov. 2023 )
=-0.612/( (0+-0.842)/ 1 )
=-0.612/-0.842
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Nov. 2023) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Cannabis Bioscience International Holdings  (OTCPK:CBIH) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Cannabis Bioscience International Holdings Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Cannabis Bioscience International Holdings's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) Business Description

Traded in Other Exchanges
N/A
Address
6201 Bonhomme Road, Suite 466S, Houston, TX, USA, 77036
Cannabis Bioscience International Holdings Inc is engaged in providing educational systems relating to cannabis and services in therapeutic areas. of clinical trials and services relating to sleep disorders through its sleep center in Houston, Texas. The Company generates revenue from multiple streams, namely, clinical trials, consulting fees, video courses, seminars, royalties, and merchandise sales. The company generates the majority of its revenue from clinical trials.

Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) Headlines

From GuruFocus

CHNC Completes Review of Its First Three Fiscal Quarters

By PurpleRose PurpleRose 07-12-2022

CHNC Announces a New Member of Its Board of Directors

By Marketwired Marketwired 10-20-2021